pH |
Print 3G |
Cholesterylhemisuccinate (CHEMS) |
CHEMS possesses an inverted cone shape at physiological pH. Under acidic conditions, the carboxylic acid group becomes protonated and CHEMS loses the shape releasing the protein. This transition occurs within endosome where pH is decreased during endocytosis. |
Liposomes |
[23,36,37] |
pH |
BSA |
PLGA-carboxyl group |
Undergoes deprotonation at neutral or basic pH which leads to release of the protein. |
Micelles |
[38,39] |
Enzyme (Human Neutrophil Elastase) |
Anti-inflammatory proteins/peptides |
HNE-sensitive peptides (Aminobutyric acid, Novarline, Norleucine) |
HNE diffuses into the hydrogel and splits the substrate releasing the therapeutic agent into the site of action. |
Hydrogel |
[17] |
Enzyme (Chitosanase) |
Fluorescein isothiocyanate-labeled albumin (FITC-albumin) |
Chitosan |
Enzymatic degradation weakens the capsule wall releasing the protein and the capsule is destroyed over time. Degradation is specific to chitosanase. |
Hollow capsules |
[40] |
Dual Stimuli (pH, Glucose) |
Insulin |
Concanavalin A, N-(2-(dimethylamino) ethyl)-methacrylamide |
Decrease in pH causes ionization of the amino groups causing swelling. Concanavalin A binds glucose, reducing crosslinking density in mycrohydrogels and increasing hydrophilicity leading to swelling then release of Insulin. |
Microhydrogel |
[41] |